nodes	percent_of_prediction	percent_of_DWPC	metapath
Medroxyprogesterone Acetate—NR3C1—epilepsy syndrome	0.208	1	CbGaD
Medroxyprogesterone Acetate—CYP2C8—Trimethadione—epilepsy syndrome	0.0289	0.067	CbGbCtD
Medroxyprogesterone Acetate—CYP2C8—Fosphenytoin—epilepsy syndrome	0.0271	0.063	CbGbCtD
Medroxyprogesterone Acetate—CYP2C9—Trimethadione—epilepsy syndrome	0.0201	0.0467	CbGbCtD
Medroxyprogesterone Acetate—CYP2C8—Carbamazepine—epilepsy syndrome	0.0195	0.0452	CbGbCtD
Medroxyprogesterone Acetate—CYP2C9—Fosphenytoin—epilepsy syndrome	0.0189	0.0439	CbGbCtD
Medroxyprogesterone Acetate—CYP2C8—Primidone—epilepsy syndrome	0.0182	0.0422	CbGbCtD
Medroxyprogesterone Acetate—CYP2C8—Phenytoin—epilepsy syndrome	0.0175	0.0406	CbGbCtD
Medroxyprogesterone Acetate—CYP2C8—Propofol—epilepsy syndrome	0.0163	0.0378	CbGbCtD
Medroxyprogesterone Acetate—CYP2C8—Phenobarbital—epilepsy syndrome	0.0156	0.0362	CbGbCtD
Medroxyprogesterone Acetate—CYP2C8—Diazepam—epilepsy syndrome	0.0148	0.0343	CbGbCtD
Medroxyprogesterone Acetate—CYP2C9—Carbamazepine—epilepsy syndrome	0.0136	0.0316	CbGbCtD
Medroxyprogesterone Acetate—CYP2C9—Primidone—epilepsy syndrome	0.0127	0.0295	CbGbCtD
Medroxyprogesterone Acetate—CYP3A4—Oxcarbazepine—epilepsy syndrome	0.0126	0.0292	CbGbCtD
Medroxyprogesterone Acetate—CYP2C9—Phenytoin—epilepsy syndrome	0.0122	0.0283	CbGbCtD
Medroxyprogesterone Acetate—CYP3A4—Trimethadione—epilepsy syndrome	0.0117	0.0272	CbGbCtD
Medroxyprogesterone Acetate—CYP3A4—Felbamate—epilepsy syndrome	0.0117	0.0272	CbGbCtD
Medroxyprogesterone Acetate—CYP2C8—Valproic Acid—epilepsy syndrome	0.0116	0.027	CbGbCtD
Medroxyprogesterone Acetate—CYP2C9—Propofol—epilepsy syndrome	0.0114	0.0264	CbGbCtD
Medroxyprogesterone Acetate—CYP3A4—Fosphenytoin—epilepsy syndrome	0.011	0.0255	CbGbCtD
Medroxyprogesterone Acetate—CYP2C9—Phenobarbital—epilepsy syndrome	0.0109	0.0252	CbGbCtD
Medroxyprogesterone Acetate—CYP2C9—Diazepam—epilepsy syndrome	0.0103	0.0239	CbGbCtD
Medroxyprogesterone Acetate—CYP3A4—Clonazepam—epilepsy syndrome	0.00995	0.0231	CbGbCtD
Medroxyprogesterone Acetate—CYP3A4—Clobazam—epilepsy syndrome	0.00954	0.0221	CbGbCtD
Medroxyprogesterone Acetate—CYP2C9—Valproic Acid—epilepsy syndrome	0.00812	0.0189	CbGbCtD
Medroxyprogesterone Acetate—CYP3A4—Rufinamide—epilepsy syndrome	0.00811	0.0188	CbGbCtD
Medroxyprogesterone Acetate—CYP3A4—Carbamazepine—epilepsy syndrome	0.0079	0.0183	CbGbCtD
Medroxyprogesterone Acetate—CYP3A4—Primidone—epilepsy syndrome	0.00738	0.0171	CbGbCtD
Medroxyprogesterone Acetate—CYP3A4—Phenytoin—epilepsy syndrome	0.00709	0.0165	CbGbCtD
Medroxyprogesterone Acetate—CYP3A4—Propofol—epilepsy syndrome	0.00661	0.0153	CbGbCtD
Medroxyprogesterone Acetate—CYP3A4—Phenobarbital—epilepsy syndrome	0.00632	0.0147	CbGbCtD
Medroxyprogesterone Acetate—CYP3A4—Acetazolamide—epilepsy syndrome	0.00632	0.0147	CbGbCtD
Medroxyprogesterone Acetate—CYP3A4—Midazolam—epilepsy syndrome	0.00623	0.0145	CbGbCtD
Medroxyprogesterone Acetate—CYP3A4—Diazepam—epilepsy syndrome	0.00599	0.0139	CbGbCtD
Medroxyprogesterone Acetate—CYP3A4—Zonisamide—epilepsy syndrome	0.00585	0.0136	CbGbCtD
Medroxyprogesterone Acetate—CYP3A4—Valproic Acid—epilepsy syndrome	0.00472	0.011	CbGbCtD
Medroxyprogesterone Acetate—CYP3A4—Topiramate—epilepsy syndrome	0.00426	0.00989	CbGbCtD
Medroxyprogesterone Acetate—SHBG—hindbrain—epilepsy syndrome	0.00132	0.0554	CbGeAlD
Medroxyprogesterone Acetate—HSD3B2—head—epilepsy syndrome	0.00132	0.0553	CbGeAlD
Medroxyprogesterone Acetate—HSD3B2—nervous system—epilepsy syndrome	0.00125	0.0525	CbGeAlD
Medroxyprogesterone Acetate—HSD3B2—central nervous system—epilepsy syndrome	0.00121	0.0505	CbGeAlD
Medroxyprogesterone Acetate—PGR—hindbrain—epilepsy syndrome	0.00119	0.0499	CbGeAlD
Medroxyprogesterone Acetate—HSD3B2—brain—epilepsy syndrome	0.000957	0.0401	CbGeAlD
Medroxyprogesterone Acetate—ESR1—hindbrain—epilepsy syndrome	0.000932	0.039	CbGeAlD
Medroxyprogesterone Acetate—SHBG—brainstem—epilepsy syndrome	0.000758	0.0318	CbGeAlD
Medroxyprogesterone Acetate—AKR1C3—medulla oblongata—epilepsy syndrome	0.000703	0.0295	CbGeAlD
Medroxyprogesterone Acetate—NR3C1—hindbrain—epilepsy syndrome	0.000687	0.0288	CbGeAlD
Medroxyprogesterone Acetate—AKR1C3—midbrain—epilepsy syndrome	0.000643	0.0269	CbGeAlD
Medroxyprogesterone Acetate—AKR1C3—spinal cord—epilepsy syndrome	0.000627	0.0263	CbGeAlD
Medroxyprogesterone Acetate—ESR1—brainstem—epilepsy syndrome	0.000534	0.0224	CbGeAlD
Medroxyprogesterone Acetate—AR—forebrain—epilepsy syndrome	0.000525	0.022	CbGeAlD
Medroxyprogesterone Acetate—ESR1—forebrain—epilepsy syndrome	0.000515	0.0216	CbGeAlD
Medroxyprogesterone Acetate—AKR1C3—cerebellum—epilepsy syndrome	0.000497	0.0208	CbGeAlD
Medroxyprogesterone Acetate—AR—telencephalon—epilepsy syndrome	0.000483	0.0202	CbGeAlD
Medroxyprogesterone Acetate—ESR1—telencephalon—epilepsy syndrome	0.000474	0.0199	CbGeAlD
Medroxyprogesterone Acetate—AKR1C3—brain—epilepsy syndrome	0.000404	0.0169	CbGeAlD
Medroxyprogesterone Acetate—NR3C1—brainstem—epilepsy syndrome	0.000394	0.0165	CbGeAlD
Medroxyprogesterone Acetate—SHBG—central nervous system—epilepsy syndrome	0.000382	0.016	CbGeAlD
Medroxyprogesterone Acetate—NR3C1—forebrain—epilepsy syndrome	0.00038	0.0159	CbGeAlD
Medroxyprogesterone Acetate—PGR—head—epilepsy syndrome	0.000377	0.0158	CbGeAlD
Medroxyprogesterone Acetate—SHBG—cerebellum—epilepsy syndrome	0.000374	0.0157	CbGeAlD
Medroxyprogesterone Acetate—PGR—nervous system—epilepsy syndrome	0.000358	0.015	CbGeAlD
Medroxyprogesterone Acetate—NR3C1—telencephalon—epilepsy syndrome	0.00035	0.0147	CbGeAlD
Medroxyprogesterone Acetate—PGR—central nervous system—epilepsy syndrome	0.000344	0.0144	CbGeAlD
Medroxyprogesterone Acetate—AR—spinal cord—epilepsy syndrome	0.000338	0.0142	CbGeAlD
Medroxyprogesterone Acetate—PGR—cerebellum—epilepsy syndrome	0.000337	0.0141	CbGeAlD
Medroxyprogesterone Acetate—Cyproterone acetate—NR3C1—epilepsy syndrome	0.000334	0.0826	CrCbGaD
Medroxyprogesterone Acetate—SHBG—brain—epilepsy syndrome	0.000304	0.0127	CbGeAlD
Medroxyprogesterone Acetate—AR—head—epilepsy syndrome	0.000301	0.0126	CbGeAlD
Medroxyprogesterone Acetate—ESR1—head—epilepsy syndrome	0.000295	0.0124	CbGeAlD
Medroxyprogesterone Acetate—AR—nervous system—epilepsy syndrome	0.000285	0.0119	CbGeAlD
Medroxyprogesterone Acetate—ESR1—nervous system—epilepsy syndrome	0.00028	0.0117	CbGeAlD
Medroxyprogesterone Acetate—NR3C1—medulla oblongata—epilepsy syndrome	0.000275	0.0115	CbGeAlD
Medroxyprogesterone Acetate—AR—central nervous system—epilepsy syndrome	0.000274	0.0115	CbGeAlD
Medroxyprogesterone Acetate—PGR—brain—epilepsy syndrome	0.000273	0.0115	CbGeAlD
Medroxyprogesterone Acetate—Spironolactone—SLCO1A2—epilepsy syndrome	0.000273	0.0673	CrCbGaD
Medroxyprogesterone Acetate—ESR1—central nervous system—epilepsy syndrome	0.000269	0.0113	CbGeAlD
Medroxyprogesterone Acetate—ESR1—cerebellum—epilepsy syndrome	0.000263	0.011	CbGeAlD
Medroxyprogesterone Acetate—NR3C1—midbrain—epilepsy syndrome	0.000251	0.0105	CbGeAlD
Medroxyprogesterone Acetate—NR3C1—spinal cord—epilepsy syndrome	0.000245	0.0103	CbGeAlD
Medroxyprogesterone Acetate—Methyltestosterone—SLCO1A2—epilepsy syndrome	0.00024	0.0594	CrCbGaD
Medroxyprogesterone Acetate—AR—brain—epilepsy syndrome	0.000218	0.00913	CbGeAlD
Medroxyprogesterone Acetate—NR3C1—head—epilepsy syndrome	0.000218	0.00912	CbGeAlD
Medroxyprogesterone Acetate—Prednicarbate—NR3C1—epilepsy syndrome	0.000216	0.0533	CrCbGaD
Medroxyprogesterone Acetate—ESR1—brain—epilepsy syndrome	0.000214	0.00896	CbGeAlD
Medroxyprogesterone Acetate—NR3C1—nervous system—epilepsy syndrome	0.000206	0.00865	CbGeAlD
Medroxyprogesterone Acetate—NR3C1—central nervous system—epilepsy syndrome	0.000199	0.00833	CbGeAlD
Medroxyprogesterone Acetate—NR3C1—cerebellum—epilepsy syndrome	0.000194	0.00814	CbGeAlD
Medroxyprogesterone Acetate—Hydrocortisone—SLCO1A2—epilepsy syndrome	0.000181	0.0447	CrCbGaD
Medroxyprogesterone Acetate—Medrysone—NR3C1—epilepsy syndrome	0.000181	0.0446	CrCbGaD
Medroxyprogesterone Acetate—CYP2C8—brain—epilepsy syndrome	0.000176	0.00738	CbGeAlD
Medroxyprogesterone Acetate—Flurandrenolide—NR3C1—epilepsy syndrome	0.000174	0.043	CrCbGaD
Medroxyprogesterone Acetate—Drospirenone—BCHE—epilepsy syndrome	0.000172	0.0425	CrCbGaD
Medroxyprogesterone Acetate—Hydrocortamate—NR3C1—epilepsy syndrome	0.000168	0.0416	CrCbGaD
Medroxyprogesterone Acetate—Cortisone acetate—NR3C1—epilepsy syndrome	0.000166	0.041	CrCbGaD
Medroxyprogesterone Acetate—Megestrol acetate—NR3C1—epilepsy syndrome	0.00016	0.0395	CrCbGaD
Medroxyprogesterone Acetate—NR3C1—brain—epilepsy syndrome	0.000158	0.00661	CbGeAlD
Medroxyprogesterone Acetate—CYP3A4—nervous system—epilepsy syndrome	0.000156	0.00654	CbGeAlD
Medroxyprogesterone Acetate—CYP3A4—central nervous system—epilepsy syndrome	0.00015	0.0063	CbGeAlD
Medroxyprogesterone Acetate—Testosterone—SLCO1A2—epilepsy syndrome	0.000139	0.0345	CrCbGaD
Medroxyprogesterone Acetate—Fludrocortisone—NR3C1—epilepsy syndrome	0.000131	0.0325	CrCbGaD
Medroxyprogesterone Acetate—Spironolactone—ABCC2—epilepsy syndrome	0.00013	0.0322	CrCbGaD
Medroxyprogesterone Acetate—Fluorometholone—NR3C1—epilepsy syndrome	0.000127	0.0313	CrCbGaD
Medroxyprogesterone Acetate—Methylprednisolone—NR3C1—epilepsy syndrome	0.000122	0.0303	CrCbGaD
Medroxyprogesterone Acetate—Testosterone—CYP11A1—epilepsy syndrome	0.000121	0.03	CrCbGaD
Medroxyprogesterone Acetate—Fluoxymesterone—NR3C1—epilepsy syndrome	0.000109	0.0268	CrCbGaD
Medroxyprogesterone Acetate—Spironolactone—NR3C1—epilepsy syndrome	9.94e-05	0.0246	CrCbGaD
Medroxyprogesterone Acetate—Drospirenone—PTGS2—epilepsy syndrome	7.92e-05	0.0196	CrCbGaD
Medroxyprogesterone Acetate—Megestrol acetate—ABCB1—epilepsy syndrome	7.71e-05	0.0191	CrCbGaD
Medroxyprogesterone Acetate—Hydrocortisone—ABCG2—epilepsy syndrome	7.65e-05	0.0189	CrCbGaD
Medroxyprogesterone Acetate—Hydrocortisone—NR3C1—epilepsy syndrome	6.6e-05	0.0163	CrCbGaD
Medroxyprogesterone Acetate—Methylprednisolone—ABCB1—epilepsy syndrome	5.91e-05	0.0146	CrCbGaD
Medroxyprogesterone Acetate—Testosterone—ABCG2—epilepsy syndrome	5.9e-05	0.0146	CrCbGaD
Medroxyprogesterone Acetate—Progesterone—NR3C1—epilepsy syndrome	5.38e-05	0.0133	CrCbGaD
Medroxyprogesterone Acetate—Progesterone—CYP2C19—epilepsy syndrome	4.9e-05	0.0121	CrCbGaD
Medroxyprogesterone Acetate—Spironolactone—ABCB1—epilepsy syndrome	4.8e-05	0.0119	CrCbGaD
Medroxyprogesterone Acetate—Testosterone—CYP2C19—epilepsy syndrome	4.63e-05	0.0115	CrCbGaD
Medroxyprogesterone Acetate—Methyltestosterone—ALB—epilepsy syndrome	4.43e-05	0.011	CrCbGaD
Medroxyprogesterone Acetate—Progesterone—CYP2D6—epilepsy syndrome	3.63e-05	0.00898	CrCbGaD
Medroxyprogesterone Acetate—Hydrocortisone—ABCB1—epilepsy syndrome	3.19e-05	0.00787	CrCbGaD
Medroxyprogesterone Acetate—Visual impairment—Topiramate—epilepsy syndrome	3.02e-05	0.000123	CcSEcCtD
Medroxyprogesterone Acetate—Arthralgia—Pregabalin—epilepsy syndrome	3.01e-05	0.000122	CcSEcCtD
Medroxyprogesterone Acetate—Myalgia—Pregabalin—epilepsy syndrome	3.01e-05	0.000122	CcSEcCtD
Medroxyprogesterone Acetate—Chest pain—Pregabalin—epilepsy syndrome	3.01e-05	0.000122	CcSEcCtD
Medroxyprogesterone Acetate—Ill-defined disorder—Gabapentin—epilepsy syndrome	3.01e-05	0.000122	CcSEcCtD
Medroxyprogesterone Acetate—Dizziness—Zonisamide—epilepsy syndrome	3.01e-05	0.000122	CcSEcCtD
Medroxyprogesterone Acetate—Headache—Diazepam—epilepsy syndrome	3.01e-05	0.000122	CcSEcCtD
Medroxyprogesterone Acetate—Anxiety—Pregabalin—epilepsy syndrome	3e-05	0.000122	CcSEcCtD
Medroxyprogesterone Acetate—Diarrhoea—Clonazepam—epilepsy syndrome	3e-05	0.000122	CcSEcCtD
Medroxyprogesterone Acetate—Anaemia—Gabapentin—epilepsy syndrome	3e-05	0.000122	CcSEcCtD
Medroxyprogesterone Acetate—Unspecified disorder of skin and subcutaneous tissue—Pregabalin—epilepsy syndrome	2.99e-05	0.000121	CcSEcCtD
Medroxyprogesterone Acetate—Hypotension—Valproic Acid—epilepsy syndrome	2.99e-05	0.000121	CcSEcCtD
Medroxyprogesterone Acetate—Asthenia—Carbamazepine—epilepsy syndrome	2.99e-05	0.000121	CcSEcCtD
Medroxyprogesterone Acetate—Agitation—Gabapentin—epilepsy syndrome	2.98e-05	0.000121	CcSEcCtD
Medroxyprogesterone Acetate—Diarrhoea—Phenytoin—epilepsy syndrome	2.98e-05	0.000121	CcSEcCtD
Medroxyprogesterone Acetate—Discomfort—Pregabalin—epilepsy syndrome	2.98e-05	0.000121	CcSEcCtD
Medroxyprogesterone Acetate—Nausea—Fosphenytoin—epilepsy syndrome	2.98e-05	0.000121	CcSEcCtD
Medroxyprogesterone Acetate—Diarrhoea—Oxcarbazepine—epilepsy syndrome	2.97e-05	0.00012	CcSEcCtD
Medroxyprogesterone Acetate—Erythema multiforme—Topiramate—epilepsy syndrome	2.97e-05	0.00012	CcSEcCtD
Medroxyprogesterone Acetate—Angioedema—Gabapentin—epilepsy syndrome	2.97e-05	0.00012	CcSEcCtD
Medroxyprogesterone Acetate—Hypersensitivity—Lamotrigine—epilepsy syndrome	2.96e-05	0.00012	CcSEcCtD
Medroxyprogesterone Acetate—Vomiting—Felbamate—epilepsy syndrome	2.96e-05	0.00012	CcSEcCtD
Medroxyprogesterone Acetate—Dry mouth—Pregabalin—epilepsy syndrome	2.95e-05	0.00012	CcSEcCtD
Medroxyprogesterone Acetate—Pruritus—Carbamazepine—epilepsy syndrome	2.94e-05	0.000119	CcSEcCtD
Medroxyprogesterone Acetate—Rash—Felbamate—epilepsy syndrome	2.93e-05	0.000119	CcSEcCtD
Medroxyprogesterone Acetate—Eye disorder—Topiramate—epilepsy syndrome	2.93e-05	0.000119	CcSEcCtD
Medroxyprogesterone Acetate—Dermatitis—Felbamate—epilepsy syndrome	2.93e-05	0.000119	CcSEcCtD
Medroxyprogesterone Acetate—Malaise—Gabapentin—epilepsy syndrome	2.93e-05	0.000119	CcSEcCtD
Medroxyprogesterone Acetate—Tinnitus—Topiramate—epilepsy syndrome	2.93e-05	0.000119	CcSEcCtD
Medroxyprogesterone Acetate—Vertigo—Gabapentin—epilepsy syndrome	2.92e-05	0.000118	CcSEcCtD
Medroxyprogesterone Acetate—Headache—Felbamate—epilepsy syndrome	2.92e-05	0.000118	CcSEcCtD
Medroxyprogesterone Acetate—Confusional state—Pregabalin—epilepsy syndrome	2.91e-05	0.000118	CcSEcCtD
Medroxyprogesterone Acetate—Musculoskeletal discomfort—Valproic Acid—epilepsy syndrome	2.91e-05	0.000118	CcSEcCtD
Medroxyprogesterone Acetate—Cardiac disorder—Topiramate—epilepsy syndrome	2.91e-05	0.000118	CcSEcCtD
Medroxyprogesterone Acetate—Syncope—Gabapentin—epilepsy syndrome	2.91e-05	0.000118	CcSEcCtD
Medroxyprogesterone Acetate—Dizziness—Clonazepam—epilepsy syndrome	2.9e-05	0.000118	CcSEcCtD
Medroxyprogesterone Acetate—Nausea—Vigabatrin—epilepsy syndrome	2.9e-05	0.000118	CcSEcCtD
Medroxyprogesterone Acetate—Vomiting—Zonisamide—epilepsy syndrome	2.9e-05	0.000118	CcSEcCtD
Medroxyprogesterone Acetate—Insomnia—Valproic Acid—epilepsy syndrome	2.89e-05	0.000117	CcSEcCtD
Medroxyprogesterone Acetate—Anaphylactic shock—Pregabalin—epilepsy syndrome	2.89e-05	0.000117	CcSEcCtD
Medroxyprogesterone Acetate—Oedema—Pregabalin—epilepsy syndrome	2.89e-05	0.000117	CcSEcCtD
Medroxyprogesterone Acetate—Asthenia—Lamotrigine—epilepsy syndrome	2.89e-05	0.000117	CcSEcCtD
Medroxyprogesterone Acetate—Dizziness—Phenytoin—epilepsy syndrome	2.88e-05	0.000117	CcSEcCtD
Medroxyprogesterone Acetate—Rash—Zonisamide—epilepsy syndrome	2.87e-05	0.000117	CcSEcCtD
Medroxyprogesterone Acetate—Infection—Pregabalin—epilepsy syndrome	2.87e-05	0.000116	CcSEcCtD
Medroxyprogesterone Acetate—Paraesthesia—Valproic Acid—epilepsy syndrome	2.87e-05	0.000116	CcSEcCtD
Medroxyprogesterone Acetate—Palpitations—Gabapentin—epilepsy syndrome	2.87e-05	0.000116	CcSEcCtD
Medroxyprogesterone Acetate—Dermatitis—Zonisamide—epilepsy syndrome	2.87e-05	0.000116	CcSEcCtD
Medroxyprogesterone Acetate—Dizziness—Oxcarbazepine—epilepsy syndrome	2.87e-05	0.000116	CcSEcCtD
Medroxyprogesterone Acetate—Nausea—Diazepam—epilepsy syndrome	2.86e-05	0.000116	CcSEcCtD
Medroxyprogesterone Acetate—Loss of consciousness—Gabapentin—epilepsy syndrome	2.85e-05	0.000116	CcSEcCtD
Medroxyprogesterone Acetate—Headache—Zonisamide—epilepsy syndrome	2.85e-05	0.000116	CcSEcCtD
Medroxyprogesterone Acetate—Dyspnoea—Valproic Acid—epilepsy syndrome	2.85e-05	0.000116	CcSEcCtD
Medroxyprogesterone Acetate—Diarrhoea—Carbamazepine—epilepsy syndrome	2.85e-05	0.000116	CcSEcCtD
Medroxyprogesterone Acetate—Angiopathy—Topiramate—epilepsy syndrome	2.85e-05	0.000116	CcSEcCtD
Medroxyprogesterone Acetate—Pruritus—Lamotrigine—epilepsy syndrome	2.85e-05	0.000115	CcSEcCtD
Medroxyprogesterone Acetate—Shock—Pregabalin—epilepsy syndrome	2.84e-05	0.000115	CcSEcCtD
Medroxyprogesterone Acetate—Somnolence—Valproic Acid—epilepsy syndrome	2.84e-05	0.000115	CcSEcCtD
Medroxyprogesterone Acetate—Immune system disorder—Topiramate—epilepsy syndrome	2.83e-05	0.000115	CcSEcCtD
Medroxyprogesterone Acetate—Nervous system disorder—Pregabalin—epilepsy syndrome	2.83e-05	0.000115	CcSEcCtD
Medroxyprogesterone Acetate—Thrombocytopenia—Pregabalin—epilepsy syndrome	2.83e-05	0.000115	CcSEcCtD
Medroxyprogesterone Acetate—Mediastinal disorder—Topiramate—epilepsy syndrome	2.83e-05	0.000115	CcSEcCtD
Medroxyprogesterone Acetate—Tachycardia—Pregabalin—epilepsy syndrome	2.82e-05	0.000114	CcSEcCtD
Medroxyprogesterone Acetate—Chills—Topiramate—epilepsy syndrome	2.82e-05	0.000114	CcSEcCtD
Medroxyprogesterone Acetate—Dyspepsia—Valproic Acid—epilepsy syndrome	2.81e-05	0.000114	CcSEcCtD
Medroxyprogesterone Acetate—Convulsion—Gabapentin—epilepsy syndrome	2.81e-05	0.000114	CcSEcCtD
Medroxyprogesterone Acetate—Skin disorder—Pregabalin—epilepsy syndrome	2.81e-05	0.000114	CcSEcCtD
Medroxyprogesterone Acetate—Hyperhidrosis—Pregabalin—epilepsy syndrome	2.79e-05	0.000113	CcSEcCtD
Medroxyprogesterone Acetate—Vomiting—Clonazepam—epilepsy syndrome	2.79e-05	0.000113	CcSEcCtD
Medroxyprogesterone Acetate—Decreased appetite—Valproic Acid—epilepsy syndrome	2.78e-05	0.000113	CcSEcCtD
Medroxyprogesterone Acetate—Alopecia—Topiramate—epilepsy syndrome	2.77e-05	0.000113	CcSEcCtD
Medroxyprogesterone Acetate—Vomiting—Phenytoin—epilepsy syndrome	2.77e-05	0.000112	CcSEcCtD
Medroxyprogesterone Acetate—Rash—Clonazepam—epilepsy syndrome	2.77e-05	0.000112	CcSEcCtD
Medroxyprogesterone Acetate—Dermatitis—Clonazepam—epilepsy syndrome	2.77e-05	0.000112	CcSEcCtD
Medroxyprogesterone Acetate—Chest pain—Gabapentin—epilepsy syndrome	2.76e-05	0.000112	CcSEcCtD
Medroxyprogesterone Acetate—Myalgia—Gabapentin—epilepsy syndrome	2.76e-05	0.000112	CcSEcCtD
Medroxyprogesterone Acetate—Arthralgia—Gabapentin—epilepsy syndrome	2.76e-05	0.000112	CcSEcCtD
Medroxyprogesterone Acetate—Nausea—Felbamate—epilepsy syndrome	2.76e-05	0.000112	CcSEcCtD
Medroxyprogesterone Acetate—Gastrointestinal disorder—Valproic Acid—epilepsy syndrome	2.76e-05	0.000112	CcSEcCtD
Medroxyprogesterone Acetate—Vomiting—Oxcarbazepine—epilepsy syndrome	2.76e-05	0.000112	CcSEcCtD
Medroxyprogesterone Acetate—Fatigue—Valproic Acid—epilepsy syndrome	2.76e-05	0.000112	CcSEcCtD
Medroxyprogesterone Acetate—Anxiety—Gabapentin—epilepsy syndrome	2.75e-05	0.000112	CcSEcCtD
Medroxyprogesterone Acetate—Anorexia—Pregabalin—epilepsy syndrome	2.75e-05	0.000112	CcSEcCtD
Medroxyprogesterone Acetate—Dizziness—Carbamazepine—epilepsy syndrome	2.75e-05	0.000112	CcSEcCtD
Medroxyprogesterone Acetate—Diarrhoea—Lamotrigine—epilepsy syndrome	2.75e-05	0.000112	CcSEcCtD
Medroxyprogesterone Acetate—Headache—Clonazepam—epilepsy syndrome	2.75e-05	0.000112	CcSEcCtD
Medroxyprogesterone Acetate—Rash—Phenytoin—epilepsy syndrome	2.75e-05	0.000112	CcSEcCtD
Medroxyprogesterone Acetate—Mental disorder—Topiramate—epilepsy syndrome	2.75e-05	0.000112	CcSEcCtD
Medroxyprogesterone Acetate—Dermatitis—Phenytoin—epilepsy syndrome	2.75e-05	0.000111	CcSEcCtD
Medroxyprogesterone Acetate—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—epilepsy syndrome	2.75e-05	0.000111	CcSEcCtD
Medroxyprogesterone Acetate—Rash—Oxcarbazepine—epilepsy syndrome	2.73e-05	0.000111	CcSEcCtD
Medroxyprogesterone Acetate—Constipation—Valproic Acid—epilepsy syndrome	2.73e-05	0.000111	CcSEcCtD
Medroxyprogesterone Acetate—Dermatitis—Oxcarbazepine—epilepsy syndrome	2.73e-05	0.000111	CcSEcCtD
Medroxyprogesterone Acetate—Headache—Phenytoin—epilepsy syndrome	2.73e-05	0.000111	CcSEcCtD
Medroxyprogesterone Acetate—Erythema—Topiramate—epilepsy syndrome	2.73e-05	0.000111	CcSEcCtD
Medroxyprogesterone Acetate—Malnutrition—Topiramate—epilepsy syndrome	2.73e-05	0.000111	CcSEcCtD
Medroxyprogesterone Acetate—Discomfort—Gabapentin—epilepsy syndrome	2.73e-05	0.000111	CcSEcCtD
Medroxyprogesterone Acetate—Headache—Oxcarbazepine—epilepsy syndrome	2.72e-05	0.00011	CcSEcCtD
Medroxyprogesterone Acetate—Nausea—Zonisamide—epilepsy syndrome	2.71e-05	0.00011	CcSEcCtD
Medroxyprogesterone Acetate—Dry mouth—Gabapentin—epilepsy syndrome	2.7e-05	0.00011	CcSEcCtD
Medroxyprogesterone Acetate—Hypotension—Pregabalin—epilepsy syndrome	2.7e-05	0.00011	CcSEcCtD
Medroxyprogesterone Acetate—Flatulence—Topiramate—epilepsy syndrome	2.69e-05	0.000109	CcSEcCtD
Medroxyprogesterone Acetate—Tension—Topiramate—epilepsy syndrome	2.68e-05	0.000109	CcSEcCtD
Medroxyprogesterone Acetate—Dysgeusia—Topiramate—epilepsy syndrome	2.68e-05	0.000109	CcSEcCtD
Medroxyprogesterone Acetate—Confusional state—Gabapentin—epilepsy syndrome	2.67e-05	0.000108	CcSEcCtD
Medroxyprogesterone Acetate—Dizziness—Lamotrigine—epilepsy syndrome	2.66e-05	0.000108	CcSEcCtD
Medroxyprogesterone Acetate—Nervousness—Topiramate—epilepsy syndrome	2.65e-05	0.000108	CcSEcCtD
Medroxyprogesterone Acetate—Anaphylactic shock—Gabapentin—epilepsy syndrome	2.65e-05	0.000108	CcSEcCtD
Medroxyprogesterone Acetate—Oedema—Gabapentin—epilepsy syndrome	2.65e-05	0.000108	CcSEcCtD
Medroxyprogesterone Acetate—Vomiting—Carbamazepine—epilepsy syndrome	2.65e-05	0.000107	CcSEcCtD
Medroxyprogesterone Acetate—Back pain—Topiramate—epilepsy syndrome	2.64e-05	0.000107	CcSEcCtD
Medroxyprogesterone Acetate—Feeling abnormal—Valproic Acid—epilepsy syndrome	2.63e-05	0.000107	CcSEcCtD
Medroxyprogesterone Acetate—Musculoskeletal discomfort—Pregabalin—epilepsy syndrome	2.63e-05	0.000107	CcSEcCtD
Medroxyprogesterone Acetate—Infection—Gabapentin—epilepsy syndrome	2.63e-05	0.000107	CcSEcCtD
Medroxyprogesterone Acetate—Muscle spasms—Topiramate—epilepsy syndrome	2.63e-05	0.000107	CcSEcCtD
Medroxyprogesterone Acetate—Rash—Carbamazepine—epilepsy syndrome	2.62e-05	0.000106	CcSEcCtD
Medroxyprogesterone Acetate—Dermatitis—Carbamazepine—epilepsy syndrome	2.62e-05	0.000106	CcSEcCtD
Medroxyprogesterone Acetate—Gastrointestinal pain—Valproic Acid—epilepsy syndrome	2.61e-05	0.000106	CcSEcCtD
Medroxyprogesterone Acetate—Insomnia—Pregabalin—epilepsy syndrome	2.61e-05	0.000106	CcSEcCtD
Medroxyprogesterone Acetate—Nausea—Clonazepam—epilepsy syndrome	2.61e-05	0.000106	CcSEcCtD
Medroxyprogesterone Acetate—Headache—Carbamazepine—epilepsy syndrome	2.61e-05	0.000106	CcSEcCtD
Medroxyprogesterone Acetate—Shock—Gabapentin—epilepsy syndrome	2.61e-05	0.000106	CcSEcCtD
Medroxyprogesterone Acetate—Nervous system disorder—Gabapentin—epilepsy syndrome	2.6e-05	0.000105	CcSEcCtD
Medroxyprogesterone Acetate—Progesterone—ABCB1—epilepsy syndrome	2.6e-05	0.00641	CrCbGaD
Medroxyprogesterone Acetate—Paraesthesia—Pregabalin—epilepsy syndrome	2.59e-05	0.000105	CcSEcCtD
Medroxyprogesterone Acetate—Thrombocytopenia—Gabapentin—epilepsy syndrome	2.59e-05	0.000105	CcSEcCtD
Medroxyprogesterone Acetate—Nausea—Phenytoin—epilepsy syndrome	2.59e-05	0.000105	CcSEcCtD
Medroxyprogesterone Acetate—Tachycardia—Gabapentin—epilepsy syndrome	2.59e-05	0.000105	CcSEcCtD
Medroxyprogesterone Acetate—Dyspnoea—Pregabalin—epilepsy syndrome	2.58e-05	0.000105	CcSEcCtD
Medroxyprogesterone Acetate—Nausea—Oxcarbazepine—epilepsy syndrome	2.58e-05	0.000105	CcSEcCtD
Medroxyprogesterone Acetate—Skin disorder—Gabapentin—epilepsy syndrome	2.57e-05	0.000104	CcSEcCtD
Medroxyprogesterone Acetate—Testosterone—ALB—epilepsy syndrome	2.57e-05	0.00635	CrCbGaD
Medroxyprogesterone Acetate—Somnolence—Pregabalin—epilepsy syndrome	2.57e-05	0.000104	CcSEcCtD
Medroxyprogesterone Acetate—Hyperhidrosis—Gabapentin—epilepsy syndrome	2.56e-05	0.000104	CcSEcCtD
Medroxyprogesterone Acetate—Tremor—Topiramate—epilepsy syndrome	2.56e-05	0.000104	CcSEcCtD
Medroxyprogesterone Acetate—Vomiting—Lamotrigine—epilepsy syndrome	2.56e-05	0.000104	CcSEcCtD
Medroxyprogesterone Acetate—Urticaria—Valproic Acid—epilepsy syndrome	2.54e-05	0.000103	CcSEcCtD
Medroxyprogesterone Acetate—Rash—Lamotrigine—epilepsy syndrome	2.54e-05	0.000103	CcSEcCtD
Medroxyprogesterone Acetate—Ill-defined disorder—Topiramate—epilepsy syndrome	2.53e-05	0.000103	CcSEcCtD
Medroxyprogesterone Acetate—Dermatitis—Lamotrigine—epilepsy syndrome	2.53e-05	0.000103	CcSEcCtD
Medroxyprogesterone Acetate—Abdominal pain—Valproic Acid—epilepsy syndrome	2.53e-05	0.000103	CcSEcCtD
Medroxyprogesterone Acetate—Body temperature increased—Valproic Acid—epilepsy syndrome	2.53e-05	0.000103	CcSEcCtD
Medroxyprogesterone Acetate—Anorexia—Gabapentin—epilepsy syndrome	2.53e-05	0.000102	CcSEcCtD
Medroxyprogesterone Acetate—Anaemia—Topiramate—epilepsy syndrome	2.52e-05	0.000102	CcSEcCtD
Medroxyprogesterone Acetate—Headache—Lamotrigine—epilepsy syndrome	2.52e-05	0.000102	CcSEcCtD
Medroxyprogesterone Acetate—Decreased appetite—Pregabalin—epilepsy syndrome	2.51e-05	0.000102	CcSEcCtD
Medroxyprogesterone Acetate—Agitation—Topiramate—epilepsy syndrome	2.51e-05	0.000102	CcSEcCtD
Medroxyprogesterone Acetate—Gastrointestinal disorder—Pregabalin—epilepsy syndrome	2.49e-05	0.000101	CcSEcCtD
Medroxyprogesterone Acetate—Fatigue—Pregabalin—epilepsy syndrome	2.49e-05	0.000101	CcSEcCtD
Medroxyprogesterone Acetate—Hypotension—Gabapentin—epilepsy syndrome	2.48e-05	0.0001	CcSEcCtD
Medroxyprogesterone Acetate—Nausea—Carbamazepine—epilepsy syndrome	2.47e-05	0.0001	CcSEcCtD
Medroxyprogesterone Acetate—Constipation—Pregabalin—epilepsy syndrome	2.47e-05	0.0001	CcSEcCtD
Medroxyprogesterone Acetate—Malaise—Topiramate—epilepsy syndrome	2.46e-05	0.0001	CcSEcCtD
Medroxyprogesterone Acetate—Vertigo—Topiramate—epilepsy syndrome	2.45e-05	9.96e-05	CcSEcCtD
Medroxyprogesterone Acetate—Testosterone—ABCB1—epilepsy syndrome	2.45e-05	0.00606	CrCbGaD
Medroxyprogesterone Acetate—Syncope—Topiramate—epilepsy syndrome	2.45e-05	9.94e-05	CcSEcCtD
Medroxyprogesterone Acetate—Musculoskeletal discomfort—Gabapentin—epilepsy syndrome	2.41e-05	9.8e-05	CcSEcCtD
Medroxyprogesterone Acetate—Palpitations—Topiramate—epilepsy syndrome	2.41e-05	9.8e-05	CcSEcCtD
Medroxyprogesterone Acetate—Loss of consciousness—Topiramate—epilepsy syndrome	2.4e-05	9.74e-05	CcSEcCtD
Medroxyprogesterone Acetate—Insomnia—Gabapentin—epilepsy syndrome	2.4e-05	9.73e-05	CcSEcCtD
Medroxyprogesterone Acetate—Nausea—Lamotrigine—epilepsy syndrome	2.39e-05	9.7e-05	CcSEcCtD
Medroxyprogesterone Acetate—Feeling abnormal—Pregabalin—epilepsy syndrome	2.38e-05	9.66e-05	CcSEcCtD
Medroxyprogesterone Acetate—Paraesthesia—Gabapentin—epilepsy syndrome	2.38e-05	9.66e-05	CcSEcCtD
Medroxyprogesterone Acetate—Convulsion—Topiramate—epilepsy syndrome	2.37e-05	9.6e-05	CcSEcCtD
Medroxyprogesterone Acetate—Gastrointestinal pain—Pregabalin—epilepsy syndrome	2.36e-05	9.59e-05	CcSEcCtD
Medroxyprogesterone Acetate—Dyspnoea—Gabapentin—epilepsy syndrome	2.36e-05	9.59e-05	CcSEcCtD
Medroxyprogesterone Acetate—Somnolence—Gabapentin—epilepsy syndrome	2.36e-05	9.56e-05	CcSEcCtD
Medroxyprogesterone Acetate—Hypersensitivity—Valproic Acid—epilepsy syndrome	2.36e-05	9.56e-05	CcSEcCtD
Medroxyprogesterone Acetate—Dyspepsia—Gabapentin—epilepsy syndrome	2.33e-05	9.47e-05	CcSEcCtD
Medroxyprogesterone Acetate—Arthralgia—Topiramate—epilepsy syndrome	2.33e-05	9.44e-05	CcSEcCtD
Medroxyprogesterone Acetate—Myalgia—Topiramate—epilepsy syndrome	2.33e-05	9.44e-05	CcSEcCtD
Medroxyprogesterone Acetate—Chest pain—Topiramate—epilepsy syndrome	2.33e-05	9.44e-05	CcSEcCtD
Medroxyprogesterone Acetate—Anxiety—Topiramate—epilepsy syndrome	2.32e-05	9.4e-05	CcSEcCtD
Medroxyprogesterone Acetate—Unspecified disorder of skin and subcutaneous tissue—Topiramate—epilepsy syndrome	2.31e-05	9.37e-05	CcSEcCtD
Medroxyprogesterone Acetate—Decreased appetite—Gabapentin—epilepsy syndrome	2.3e-05	9.35e-05	CcSEcCtD
Medroxyprogesterone Acetate—Discomfort—Topiramate—epilepsy syndrome	2.3e-05	9.32e-05	CcSEcCtD
Medroxyprogesterone Acetate—Urticaria—Pregabalin—epilepsy syndrome	2.3e-05	9.32e-05	CcSEcCtD
Medroxyprogesterone Acetate—Asthenia—Valproic Acid—epilepsy syndrome	2.29e-05	9.31e-05	CcSEcCtD
Medroxyprogesterone Acetate—Gastrointestinal disorder—Gabapentin—epilepsy syndrome	2.29e-05	9.28e-05	CcSEcCtD
Medroxyprogesterone Acetate—Fatigue—Gabapentin—epilepsy syndrome	2.28e-05	9.27e-05	CcSEcCtD
Medroxyprogesterone Acetate—Abdominal pain—Pregabalin—epilepsy syndrome	2.28e-05	9.27e-05	CcSEcCtD
Medroxyprogesterone Acetate—Body temperature increased—Pregabalin—epilepsy syndrome	2.28e-05	9.27e-05	CcSEcCtD
Medroxyprogesterone Acetate—Dry mouth—Topiramate—epilepsy syndrome	2.27e-05	9.23e-05	CcSEcCtD
Medroxyprogesterone Acetate—Constipation—Gabapentin—epilepsy syndrome	2.27e-05	9.2e-05	CcSEcCtD
Medroxyprogesterone Acetate—Pruritus—Valproic Acid—epilepsy syndrome	2.26e-05	9.18e-05	CcSEcCtD
Medroxyprogesterone Acetate—Confusional state—Topiramate—epilepsy syndrome	2.25e-05	9.12e-05	CcSEcCtD
Medroxyprogesterone Acetate—Oedema—Topiramate—epilepsy syndrome	2.23e-05	9.05e-05	CcSEcCtD
Medroxyprogesterone Acetate—Infection—Topiramate—epilepsy syndrome	2.21e-05	8.99e-05	CcSEcCtD
Medroxyprogesterone Acetate—Shock—Topiramate—epilepsy syndrome	2.19e-05	8.9e-05	CcSEcCtD
Medroxyprogesterone Acetate—Diarrhoea—Valproic Acid—epilepsy syndrome	2.19e-05	8.87e-05	CcSEcCtD
Medroxyprogesterone Acetate—Nervous system disorder—Topiramate—epilepsy syndrome	2.19e-05	8.87e-05	CcSEcCtD
Medroxyprogesterone Acetate—Feeling abnormal—Gabapentin—epilepsy syndrome	2.18e-05	8.86e-05	CcSEcCtD
Medroxyprogesterone Acetate—Thrombocytopenia—Topiramate—epilepsy syndrome	2.18e-05	8.86e-05	CcSEcCtD
Medroxyprogesterone Acetate—Tachycardia—Topiramate—epilepsy syndrome	2.18e-05	8.83e-05	CcSEcCtD
Medroxyprogesterone Acetate—Gastrointestinal pain—Gabapentin—epilepsy syndrome	2.17e-05	8.79e-05	CcSEcCtD
Medroxyprogesterone Acetate—Skin disorder—Topiramate—epilepsy syndrome	2.17e-05	8.79e-05	CcSEcCtD
Medroxyprogesterone Acetate—Hyperhidrosis—Topiramate—epilepsy syndrome	2.16e-05	8.75e-05	CcSEcCtD
Medroxyprogesterone Acetate—Hypersensitivity—Pregabalin—epilepsy syndrome	2.13e-05	8.64e-05	CcSEcCtD
Medroxyprogesterone Acetate—Anorexia—Topiramate—epilepsy syndrome	2.13e-05	8.62e-05	CcSEcCtD
Medroxyprogesterone Acetate—Dizziness—Valproic Acid—epilepsy syndrome	2.11e-05	8.58e-05	CcSEcCtD
Medroxyprogesterone Acetate—Urticaria—Gabapentin—epilepsy syndrome	2.11e-05	8.54e-05	CcSEcCtD
Medroxyprogesterone Acetate—Abdominal pain—Gabapentin—epilepsy syndrome	2.09e-05	8.5e-05	CcSEcCtD
Medroxyprogesterone Acetate—Body temperature increased—Gabapentin—epilepsy syndrome	2.09e-05	8.5e-05	CcSEcCtD
Medroxyprogesterone Acetate—Hypotension—Topiramate—epilepsy syndrome	2.08e-05	8.45e-05	CcSEcCtD
Medroxyprogesterone Acetate—Asthenia—Pregabalin—epilepsy syndrome	2.07e-05	8.41e-05	CcSEcCtD
Medroxyprogesterone Acetate—Pruritus—Pregabalin—epilepsy syndrome	2.04e-05	8.3e-05	CcSEcCtD
Medroxyprogesterone Acetate—Vomiting—Valproic Acid—epilepsy syndrome	2.03e-05	8.25e-05	CcSEcCtD
Medroxyprogesterone Acetate—Musculoskeletal discomfort—Topiramate—epilepsy syndrome	2.03e-05	8.24e-05	CcSEcCtD
Medroxyprogesterone Acetate—Insomnia—Topiramate—epilepsy syndrome	2.02e-05	8.18e-05	CcSEcCtD
Medroxyprogesterone Acetate—Rash—Valproic Acid—epilepsy syndrome	2.02e-05	8.18e-05	CcSEcCtD
Medroxyprogesterone Acetate—Dermatitis—Valproic Acid—epilepsy syndrome	2.01e-05	8.17e-05	CcSEcCtD
Medroxyprogesterone Acetate—Headache—Valproic Acid—epilepsy syndrome	2e-05	8.13e-05	CcSEcCtD
Medroxyprogesterone Acetate—Paraesthesia—Topiramate—epilepsy syndrome	2e-05	8.12e-05	CcSEcCtD
Medroxyprogesterone Acetate—Dyspnoea—Topiramate—epilepsy syndrome	1.99e-05	8.07e-05	CcSEcCtD
Medroxyprogesterone Acetate—Somnolence—Topiramate—epilepsy syndrome	1.98e-05	8.04e-05	CcSEcCtD
Medroxyprogesterone Acetate—Diarrhoea—Pregabalin—epilepsy syndrome	1.98e-05	8.02e-05	CcSEcCtD
Medroxyprogesterone Acetate—Dyspepsia—Topiramate—epilepsy syndrome	1.96e-05	7.96e-05	CcSEcCtD
Medroxyprogesterone Acetate—Hypersensitivity—Gabapentin—epilepsy syndrome	1.95e-05	7.92e-05	CcSEcCtD
Medroxyprogesterone Acetate—Decreased appetite—Topiramate—epilepsy syndrome	1.94e-05	7.86e-05	CcSEcCtD
Medroxyprogesterone Acetate—Gastrointestinal disorder—Topiramate—epilepsy syndrome	1.92e-05	7.81e-05	CcSEcCtD
Medroxyprogesterone Acetate—Fatigue—Topiramate—epilepsy syndrome	1.92e-05	7.8e-05	CcSEcCtD
Medroxyprogesterone Acetate—Dizziness—Pregabalin—epilepsy syndrome	1.91e-05	7.75e-05	CcSEcCtD
Medroxyprogesterone Acetate—Constipation—Topiramate—epilepsy syndrome	1.91e-05	7.74e-05	CcSEcCtD
Medroxyprogesterone Acetate—Asthenia—Gabapentin—epilepsy syndrome	1.9e-05	7.71e-05	CcSEcCtD
Medroxyprogesterone Acetate—Nausea—Valproic Acid—epilepsy syndrome	1.9e-05	7.7e-05	CcSEcCtD
Medroxyprogesterone Acetate—Pruritus—Gabapentin—epilepsy syndrome	1.87e-05	7.61e-05	CcSEcCtD
Medroxyprogesterone Acetate—Vomiting—Pregabalin—epilepsy syndrome	1.84e-05	7.46e-05	CcSEcCtD
Medroxyprogesterone Acetate—Feeling abnormal—Topiramate—epilepsy syndrome	1.84e-05	7.45e-05	CcSEcCtD
Medroxyprogesterone Acetate—Gastrointestinal pain—Topiramate—epilepsy syndrome	1.82e-05	7.4e-05	CcSEcCtD
Medroxyprogesterone Acetate—Rash—Pregabalin—epilepsy syndrome	1.82e-05	7.39e-05	CcSEcCtD
Medroxyprogesterone Acetate—Dermatitis—Pregabalin—epilepsy syndrome	1.82e-05	7.39e-05	CcSEcCtD
Medroxyprogesterone Acetate—Diarrhoea—Gabapentin—epilepsy syndrome	1.81e-05	7.36e-05	CcSEcCtD
Medroxyprogesterone Acetate—Headache—Pregabalin—epilepsy syndrome	1.81e-05	7.35e-05	CcSEcCtD
Medroxyprogesterone Acetate—Urticaria—Topiramate—epilepsy syndrome	1.77e-05	7.19e-05	CcSEcCtD
Medroxyprogesterone Acetate—Abdominal pain—Topiramate—epilepsy syndrome	1.76e-05	7.15e-05	CcSEcCtD
Medroxyprogesterone Acetate—Body temperature increased—Topiramate—epilepsy syndrome	1.76e-05	7.15e-05	CcSEcCtD
Medroxyprogesterone Acetate—Dizziness—Gabapentin—epilepsy syndrome	1.75e-05	7.11e-05	CcSEcCtD
Medroxyprogesterone Acetate—Nausea—Pregabalin—epilepsy syndrome	1.72e-05	6.97e-05	CcSEcCtD
Medroxyprogesterone Acetate—Vomiting—Gabapentin—epilepsy syndrome	1.68e-05	6.84e-05	CcSEcCtD
Medroxyprogesterone Acetate—Rash—Gabapentin—epilepsy syndrome	1.67e-05	6.78e-05	CcSEcCtD
Medroxyprogesterone Acetate—Dermatitis—Gabapentin—epilepsy syndrome	1.67e-05	6.77e-05	CcSEcCtD
Medroxyprogesterone Acetate—Headache—Gabapentin—epilepsy syndrome	1.66e-05	6.74e-05	CcSEcCtD
Medroxyprogesterone Acetate—Hypersensitivity—Topiramate—epilepsy syndrome	1.64e-05	6.67e-05	CcSEcCtD
Medroxyprogesterone Acetate—Asthenia—Topiramate—epilepsy syndrome	1.6e-05	6.49e-05	CcSEcCtD
Medroxyprogesterone Acetate—Pruritus—Topiramate—epilepsy syndrome	1.58e-05	6.4e-05	CcSEcCtD
Medroxyprogesterone Acetate—Nausea—Gabapentin—epilepsy syndrome	1.57e-05	6.39e-05	CcSEcCtD
Medroxyprogesterone Acetate—Diarrhoea—Topiramate—epilepsy syndrome	1.53e-05	6.19e-05	CcSEcCtD
Medroxyprogesterone Acetate—Dizziness—Topiramate—epilepsy syndrome	1.47e-05	5.98e-05	CcSEcCtD
Medroxyprogesterone Acetate—Vomiting—Topiramate—epilepsy syndrome	1.42e-05	5.75e-05	CcSEcCtD
Medroxyprogesterone Acetate—Rash—Topiramate—epilepsy syndrome	1.41e-05	5.7e-05	CcSEcCtD
Medroxyprogesterone Acetate—Dermatitis—Topiramate—epilepsy syndrome	1.4e-05	5.7e-05	CcSEcCtD
Medroxyprogesterone Acetate—Headache—Topiramate—epilepsy syndrome	1.4e-05	5.67e-05	CcSEcCtD
Medroxyprogesterone Acetate—Nausea—Topiramate—epilepsy syndrome	1.32e-05	5.37e-05	CcSEcCtD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—ADSL—epilepsy syndrome	9.32e-06	0.000108	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—GBE1—epilepsy syndrome	9.3e-06	0.000107	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—PPP1R3C—epilepsy syndrome	9.3e-06	0.000107	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—GABBR1—epilepsy syndrome	9.28e-06	0.000107	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Gene Expression—NR3C1—epilepsy syndrome	9.25e-06	0.000107	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Metabolism—POMC—epilepsy syndrome	9.15e-06	0.000106	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—GLUL—epilepsy syndrome	9.14e-06	0.000106	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Integrated Pancreatic Cancer Pathway—AKT1—epilepsy syndrome	9.13e-06	0.000105	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—TSC2—epilepsy syndrome	9.1e-06	0.000105	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—epilepsy syndrome	9.09e-06	0.000105	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—AGT—epilepsy syndrome	9.09e-06	0.000105	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—AVP—epilepsy syndrome	9.08e-06	0.000105	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—CACNA1D—epilepsy syndrome	8.97e-06	0.000104	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—APOE—epilepsy syndrome	8.9e-06	0.000103	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—HRH3—epilepsy syndrome	8.89e-06	0.000103	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Disease—MTOR—epilepsy syndrome	8.79e-06	0.000102	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—OPRM1—epilepsy syndrome	8.76e-06	0.000101	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—ASAH1—epilepsy syndrome	8.75e-06	0.000101	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—KDR—epilepsy syndrome	8.72e-06	0.000101	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Disease—PTGS2—epilepsy syndrome	8.71e-06	0.000101	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—NHLRC1—epilepsy syndrome	8.71e-06	0.000101	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—EPM2A—epilepsy syndrome	8.71e-06	0.000101	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—PNPO—epilepsy syndrome	8.71e-06	0.000101	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—GAMT—epilepsy syndrome	8.71e-06	0.000101	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—HES1—epilepsy syndrome	8.58e-06	9.91e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—STXBP1—epilepsy syndrome	8.51e-06	9.83e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—PRKCB—epilepsy syndrome	8.4e-06	9.7e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—TXNRD1—epilepsy syndrome	8.39e-06	9.69e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—IL6ST—epilepsy syndrome	8.36e-06	9.66e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—FYN—epilepsy syndrome	8.35e-06	9.64e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Metabolism—ALB—epilepsy syndrome	8.34e-06	9.63e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—H2AFX—epilepsy syndrome	8.32e-06	9.61e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—MEF2C—epilepsy syndrome	8.3e-06	9.59e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—NT5E—epilepsy syndrome	8.29e-06	9.58e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—ALAD—epilepsy syndrome	8.29e-06	9.58e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—CCR3—epilepsy syndrome	8.27e-06	9.55e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—AQP1—epilepsy syndrome	8.15e-06	9.41e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—CA4—epilepsy syndrome	8.1e-06	9.35e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—QDPR—epilepsy syndrome	8.1e-06	9.35e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Biological oxidations—POMC—epilepsy syndrome	8.07e-06	9.32e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—NPY—epilepsy syndrome	8.06e-06	9.31e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—ATP2A2—epilepsy syndrome	8.06e-06	9.31e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Gene Expression—SIRT1—epilepsy syndrome	8.04e-06	9.28e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—YWHAZ—epilepsy syndrome	8.03e-06	9.27e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—NGF—epilepsy syndrome	7.94e-06	9.16e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Gene Expression—VDR—epilepsy syndrome	7.92e-06	9.15e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Gene Expression—SIRT1—epilepsy syndrome	7.91e-06	9.14e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—CACNA1A—epilepsy syndrome	7.91e-06	9.14e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—ALDH7A1—epilepsy syndrome	7.91e-06	9.14e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	7.82e-06	9.04e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Gene Expression—VDR—epilepsy syndrome	7.8e-06	9.01e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—HSPB1—epilepsy syndrome	7.77e-06	8.98e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—OXT—epilepsy syndrome	7.77e-06	8.98e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—CRH—epilepsy syndrome	7.77e-06	8.98e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—CCL3—epilepsy syndrome	7.77e-06	8.98e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—CXCL2—epilepsy syndrome	7.77e-06	8.98e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—ST3GAL3—epilepsy syndrome	7.74e-06	8.94e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—CCR5—epilepsy syndrome	7.72e-06	8.91e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—POMC—epilepsy syndrome	7.65e-06	8.83e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—COX3—epilepsy syndrome	7.61e-06	8.79e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—ADSL—epilepsy syndrome	7.58e-06	8.76e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—HTR2A—epilepsy syndrome	7.55e-06	8.72e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Gene Expression—H2AFX—epilepsy syndrome	7.51e-06	8.67e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—CCL2—epilepsy syndrome	7.48e-06	8.64e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—GLUL—epilepsy syndrome	7.44e-06	8.59e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—HSD3B2—Metabolism—AKT1—epilepsy syndrome	7.42e-06	8.57e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Gene Expression—H2AFX—epilepsy syndrome	7.39e-06	8.54e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—KCNJ11—epilepsy syndrome	7.37e-06	8.51e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—CHRM3—epilepsy syndrome	7.37e-06	8.51e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—CACNA1D—epilepsy syndrome	7.3e-06	8.43e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Metabolism—PTGS2—epilepsy syndrome	7.3e-06	8.43e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Gene Expression—YWHAZ—epilepsy syndrome	7.24e-06	8.37e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—TSC1—epilepsy syndrome	7.23e-06	8.35e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—PTK2B—epilepsy syndrome	7.23e-06	8.35e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—KCNB1—epilepsy syndrome	7.22e-06	8.33e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—CACNA2D2—epilepsy syndrome	7.22e-06	8.33e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—SLCO1A2—epilepsy syndrome	7.22e-06	8.33e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—SLC6A8—epilepsy syndrome	7.22e-06	8.33e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—PFKL—epilepsy syndrome	7.22e-06	8.33e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—TSC2—epilepsy syndrome	7.18e-06	8.29e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—AGT—epilepsy syndrome	7.17e-06	8.28e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Gene Expression—YWHAZ—epilepsy syndrome	7.13e-06	8.24e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Gene Expression—NR3C1—epilepsy syndrome	7.13e-06	8.23e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Disease—SRC—epilepsy syndrome	7.05e-06	8.14e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—CCR2—epilepsy syndrome	7.03e-06	8.12e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—NTRK2—epilepsy syndrome	7.03e-06	8.12e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—SST—epilepsy syndrome	7.03e-06	8.12e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—APOE—epilepsy syndrome	7.02e-06	8.11e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—DUSP6—epilepsy syndrome	6.97e-06	8.05e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—KDR—epilepsy syndrome	6.88e-06	7.95e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—ADRA2A—epilepsy syndrome	6.88e-06	7.95e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	6.86e-06	7.92e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—PLAT—epilepsy syndrome	6.85e-06	7.91e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—TXNRD1—epilepsy syndrome	6.83e-06	7.89e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—FGF2—epilepsy syndrome	6.76e-06	7.81e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	6.72e-06	7.76e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—AQP1—epilepsy syndrome	6.63e-06	7.66e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—PRKCB—epilepsy syndrome	6.62e-06	7.65e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—BDKRB2—epilepsy syndrome	6.61e-06	7.63e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—CXCL12—epilepsy syndrome	6.61e-06	7.63e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—NEU1—epilepsy syndrome	6.6e-06	7.62e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—UPB1—epilepsy syndrome	6.6e-06	7.62e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—ATIC—epilepsy syndrome	6.6e-06	7.62e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—IL6ST—epilepsy syndrome	6.6e-06	7.62e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—CNR1—epilepsy syndrome	6.49e-06	7.49e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—JUNB—epilepsy syndrome	6.49e-06	7.49e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—PLCB1—epilepsy syndrome	6.46e-06	7.47e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	6.37e-06	7.35e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—HSD17B4—epilepsy syndrome	6.35e-06	7.34e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—HTR7—epilepsy syndrome	6.33e-06	7.31e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—RELA—epilepsy syndrome	6.28e-06	7.25e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—MTOR—epilepsy syndrome	6.16e-06	7.11e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—HBEGF—epilepsy syndrome	6.15e-06	7.1e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—GBE1—epilepsy syndrome	6.14e-06	7.09e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—PPP1R3C—epilepsy syndrome	6.14e-06	7.09e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—POMC—epilepsy syndrome	6.03e-06	6.97e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—AKT3—epilepsy syndrome	6.03e-06	6.97e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—ABCG2—epilepsy syndrome	6.01e-06	6.94e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—KCNJ11—epilepsy syndrome	6e-06	6.92e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—CHRM3—epilepsy syndrome	6e-06	6.92e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—CCL2—epilepsy syndrome	5.9e-06	6.82e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—ADAM10—epilepsy syndrome	5.89e-06	6.8e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—CYP2C19—epilepsy syndrome	5.85e-06	6.76e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—CYP11A1—epilepsy syndrome	5.82e-06	6.72e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	5.77e-06	6.67e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—ASAH1—epilepsy syndrome	5.77e-06	6.66e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—CASP3—epilepsy syndrome	5.66e-06	6.54e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—STXBP1—epilepsy syndrome	5.61e-06	6.48e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	5.58e-06	6.45e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—S100B—epilepsy syndrome	5.57e-06	6.43e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—SOCS3—epilepsy syndrome	5.52e-06	6.37e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—CDC42—epilepsy syndrome	5.5e-06	6.36e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—JUN—epilepsy syndrome	5.5e-06	6.35e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	5.47e-06	6.32e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—NT5E—epilepsy syndrome	5.47e-06	6.32e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—ALAD—epilepsy syndrome	5.47e-06	6.32e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—MMP9—epilepsy syndrome	5.35e-06	6.18e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—FGF2—epilepsy syndrome	5.33e-06	6.16e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—AVP—epilepsy syndrome	5.33e-06	6.15e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	5.26e-06	6.08e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—CYP2D6—epilepsy syndrome	5.25e-06	6.06e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—ALDH7A1—epilepsy syndrome	5.22e-06	6.03e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—CACNA1A—epilepsy syndrome	5.22e-06	6.03e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—ST3GAL3—epilepsy syndrome	5.11e-06	5.9e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—HES1—epilepsy syndrome	5.04e-06	5.82e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—ADSL—epilepsy syndrome	5e-06	5.78e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—ADRA2A—epilepsy syndrome	5e-06	5.77e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—BCHE—epilepsy syndrome	4.98e-06	5.75e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—RELA—epilepsy syndrome	4.95e-06	5.72e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—SRC—epilepsy syndrome	4.93e-06	5.7e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—GLUL—epilepsy syndrome	4.91e-06	5.67e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—FYN—epilepsy syndrome	4.9e-06	5.66e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—ABCG2—epilepsy syndrome	4.89e-06	5.64e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—H2AFX—epilepsy syndrome	4.88e-06	5.64e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—MEF2C—epilepsy syndrome	4.87e-06	5.63e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—MTOR—epilepsy syndrome	4.86e-06	5.61e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—CACNA1D—epilepsy syndrome	4.82e-06	5.56e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—VEGFA—epilepsy syndrome	4.81e-06	5.55e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—CYP2C19—epilepsy syndrome	4.76e-06	5.5e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—SLC2A1—epilepsy syndrome	4.75e-06	5.48e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—CYP11A1—epilepsy syndrome	4.73e-06	5.47e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—YWHAZ—epilepsy syndrome	4.71e-06	5.44e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	4.7e-06	5.43e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—PLCB1—epilepsy syndrome	4.7e-06	5.42e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—TH—epilepsy syndrome	4.68e-06	5.4e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—NGF—epilepsy syndrome	4.66e-06	5.38e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	4.61e-06	5.32e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—CCR5—epilepsy syndrome	4.53e-06	5.23e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—TXNRD1—epilepsy syndrome	4.5e-06	5.2e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—CASP3—epilepsy syndrome	4.47e-06	5.16e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—HTR2A—epilepsy syndrome	4.43e-06	5.12e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Disease—AKT1—epilepsy syndrome	4.38e-06	5.06e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—AQP1—epilepsy syndrome	4.37e-06	5.05e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—JUN—epilepsy syndrome	4.34e-06	5.01e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	4.28e-06	4.95e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—CYP2D6—epilepsy syndrome	4.27e-06	4.93e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—MMP9—epilepsy syndrome	4.22e-06	4.87e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—TSC2—epilepsy syndrome	4.21e-06	4.86e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—AGT—epilepsy syndrome	4.21e-06	4.86e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—APOE—epilepsy syndrome	4.12e-06	4.76e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—ADRA2A—epilepsy syndrome	4.07e-06	4.7e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—BCHE—epilepsy syndrome	4.05e-06	4.68e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—KDR—epilepsy syndrome	4.04e-06	4.66e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—CHRM3—epilepsy syndrome	3.95e-06	4.57e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—KCNJ11—epilepsy syndrome	3.95e-06	4.57e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—HMOX1—epilepsy syndrome	3.9e-06	4.51e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—SRC—epilepsy syndrome	3.89e-06	4.49e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—PRKCB—epilepsy syndrome	3.89e-06	4.49e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—IL6ST—epilepsy syndrome	3.87e-06	4.47e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—SLC2A1—epilepsy syndrome	3.86e-06	4.46e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—CAT—epilepsy syndrome	3.85e-06	4.45e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—PLCB1—epilepsy syndrome	3.82e-06	4.41e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—TH—epilepsy syndrome	3.81e-06	4.4e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—VEGFA—epilepsy syndrome	3.79e-06	4.38e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	3.75e-06	4.33e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—ABCB1—epilepsy syndrome	3.75e-06	4.33e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Gene Expression—AKT1—epilepsy syndrome	3.72e-06	4.3e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Metabolism—AKT1—epilepsy syndrome	3.67e-06	4.23e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—POMC—epilepsy syndrome	3.54e-06	4.09e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—GPX1—epilepsy syndrome	3.48e-06	4.02e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—CCL2—epilepsy syndrome	3.46e-06	4e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—ABCG2—epilepsy syndrome	3.22e-06	3.72e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—HMOX1—epilepsy syndrome	3.18e-06	3.67e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—CYP2C19—epilepsy syndrome	3.14e-06	3.63e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—CAT—epilepsy syndrome	3.14e-06	3.62e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—FGF2—epilepsy syndrome	3.13e-06	3.62e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—CYP11A1—epilepsy syndrome	3.12e-06	3.61e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—AKT1—epilepsy syndrome	3.07e-06	3.54e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—AGT—epilepsy syndrome	3.06e-06	3.53e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—ABCB1—epilepsy syndrome	3.05e-06	3.52e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—APOE—epilepsy syndrome	2.99e-06	3.46e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—RELA—epilepsy syndrome	2.91e-06	3.36e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—MTOR—epilepsy syndrome	2.85e-06	3.29e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—GPX1—epilepsy syndrome	2.84e-06	3.27e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Gene Expression—AKT1—epilepsy syndrome	2.83e-06	3.27e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—CYP2D6—epilepsy syndrome	2.82e-06	3.25e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—ADRA2A—epilepsy syndrome	2.68e-06	3.1e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—BCHE—epilepsy syndrome	2.67e-06	3.08e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—CASP3—epilepsy syndrome	2.62e-06	3.03e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—POMC—epilepsy syndrome	2.57e-06	2.97e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—SLC2A1—epilepsy syndrome	2.55e-06	2.94e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—JUN—epilepsy syndrome	2.55e-06	2.94e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—PLCB1—epilepsy syndrome	2.52e-06	2.91e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—TH—epilepsy syndrome	2.51e-06	2.9e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—AGT—epilepsy syndrome	2.49e-06	2.87e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—MMP9—epilepsy syndrome	2.48e-06	2.86e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—APOE—epilepsy syndrome	2.44e-06	2.81e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—AKT1—epilepsy syndrome	2.42e-06	2.79e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—ALB—epilepsy syndrome	2.34e-06	2.71e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—SRC—epilepsy syndrome	2.28e-06	2.64e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—VEGFA—epilepsy syndrome	2.22e-06	2.57e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Gene Expression—AKT1—epilepsy syndrome	2.18e-06	2.52e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Gene Expression—AKT1—epilepsy syndrome	2.15e-06	2.48e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—HMOX1—epilepsy syndrome	2.1e-06	2.42e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—POMC—epilepsy syndrome	2.09e-06	2.42e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—CAT—epilepsy syndrome	2.07e-06	2.39e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—PTGS2—epilepsy syndrome	2.05e-06	2.37e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—ABCB1—epilepsy syndrome	2.01e-06	2.32e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—ALB—epilepsy syndrome	1.91e-06	2.2e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—GPX1—epilepsy syndrome	1.87e-06	2.16e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—PTGS2—epilepsy syndrome	1.67e-06	1.93e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—AGT—epilepsy syndrome	1.64e-06	1.89e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—APOE—epilepsy syndrome	1.61e-06	1.86e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—AKT1—epilepsy syndrome	1.42e-06	1.64e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—POMC—epilepsy syndrome	1.38e-06	1.59e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—ALB—epilepsy syndrome	1.26e-06	1.45e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—PTGS2—epilepsy syndrome	1.1e-06	1.27e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—AKT1—epilepsy syndrome	1.03e-06	1.19e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—AKT1—epilepsy syndrome	8.39e-07	9.69e-06	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—AKT1—epilepsy syndrome	5.53e-07	6.39e-06	CbGpPWpGaD
